EFFICACY OF IMMUNOASSAY CHROMATOGRAPHY TEST FOR HEPATITIS-C ANTIBODIES DETECTION
Abstract
Objective: To asses the efficacy of commercially available tests device method for anti HCVdetection. Methods: Total 2000 blood samples for detection of anti HCV were screened initiallyby immunochromatographic method. Those found positive on initial screening were re-tested byELISA method at the Biochemistry Laboratory of the Pakistan Medical Research Council, FatimaJinnah Medical College, Lahore. Results: Out of a total of 2,000 blood samples, 177 were foundto be initially reactive/positive for anti-HCV with immunochromatographic method. When thesereactive/positive samples were retested for confirmation with ELISA, 47 blood samples werefound to have tested falsely positive for anti-HCV. Overall 2.35% of blood samples were found tobe tested false positive for anti-HCV by immunochromatographic device method. Conclusions:Immunochromatographic device method test is rapid and simple, which can be used in setting withlimited facility when rapid testing is required. However it should not be used as sole criteria fordiagnosis but should serve the purpose of initial screening only. Further research is required toestablish the reliability of such devices for their specificity and sensitivity.Keywords: Immunochromatographic device test, Elisa testing method, anti-HCV, false positiveReferences
Dal Molin G, Tiribelli C, Campello C. Rational use of
laboratory tests in the diagnosis and management of
Hepatitis C virus infection. Ann Hepatol 2003;2(2):76–83.
WHO. Hepatitis C assays: operational characteristics report.
Blood safety and clinical technology. World Health
Organization Geneva Report 2. 2001.
Wilber JC. Development and use of laboratory tests for
Hepatitis C infections: a review. J Clin Immunoassay
;16:204–7.
Narayan S. Microbes and blood transfusion. Indian J Med
Microbiol 2001;19(3):119–26.
Sayers MH, Beatty PG, Hansen JA. HLA antibodies as a
cause of false-positive reaction. Sreening enzyme
immunoassays for antibodies to human T-lymphotropic
virus type-III. HLA antibodies as a cause of false-positive
reaction. Transfusion 1986;26(1):113–5.
Batool A, Bano KA, Khan MI, Hussain R. Antenatal
screening of women for hepatitis B and C in an out-patient
department of Sir Ganga Ram Hospital Lahore. J Dow Uni
Health Sci 2008;2(1):32–5.
Rahman M, Khan SA, Lodhi Y. Unconfirmed reactive
screening tests and their impact on donors management.
Pak J Med Sci 2008;24(4):517–9.
Wai CT, Tambyah PA. False-positive HIV-1 ELISA in
patients with Hepatitis B. Amer J Med 2002;112(9):737.
Desbois D, Vaghefi P, Savary J, Dussaix E, Roque-Afonso
AM. Sensitivity of a rapid immuno chromatographic test for
hepatitis C antibodies detection. J Clin Virol
;41(2):129–33.
Raghuraman S, Subramaniam T, Abraham P, Sridharan G.
Evaluation of a rapid assay for HCV antibody detection.
Indian J Med Microbiol 1999;17(3):140–1.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.